Skip to main content
. 2016 Jul 11;7(34):55276–55289. doi: 10.18632/oncotarget.10527

Figure 4. CD171 expression in triple-negative breast cancer.

Figure 4

A-D. Representative photos of the triple-negative breast cancer with strong and diffuse CD171 expression (A). ER (B), PgR (C), and human epidermal growth factor receptor (EGFR)-related 2 (HER2) (D) expressions were under-detectable level.